introduction
<<PREVIOUS  

Brief Introduction of Executive Officer, Dr. Yutaka Kawakami
ライン
Immunosuppressive cascades and their control by inhibitors against both cancer cells and immune cells
ライン
Suppresson cells
ライン
Recent Subjects of Research
◆　Tumor Ags expressed in cancer stem cells
◆　Mechanisms for the immunosuppression in tumor microenvironment and development of strategies
　　 to mprove
◆　Combined immunotherapy (Ag, Adjuvant, immunomodulators, Chemo/Mole. target ther., etc.)
◆　Cellular Immunotherapy (DC, T cell)
◆　Biomarkers for Immunotherapy
ライン
Yutaka Kawakami



Yutaka Kawakami, MD, PhD
Professor, Director
Div. Cellular Signaling
Inst. Advanced Med. Res.
Keio Univ. Sch. of Med.Tokyo

yutakawa@sc.itc.keio.ac.jp

http://web.sc.itc.keio.ac.jp/admedres/index-jp.html
ライン